Magnetic Resonance in Medicine
Journal
Overview
publication venue for
-
Multicenter reproducibility of quantitative susceptibility mapping in a gadolinium phantom using MEDI+0 automatic zero referencing.
81:1229-1236.
2019
-
Automated adaptive preconditioner for quantitative susceptibility mapping
2019
-
Comparison of gradient echo and gradient echo sampling of spin echo sequence for the quantification of the oxygen extraction fraction from a combined quantitative susceptibility mapping and quantitative BOLD (QSM+qBOLD) approach
2019
-
Using an artificial neural network for fast mapping of the oxygen extraction fraction with combined QSM and quantitative BOLD
2019
-
Vastly accelerated linear least-squares fitting with numerical optimization for dual-input delay-compensated quantitative liver perfusion mapping.
79:2415-2421.
2018
-
Automation of pattern recognition analysis of dynamic contrast-enhanced MRI data to characterize intratumoral vascular heterogeneity.
79:1736-1744.
2018
-
Cardiac quantitative susceptibility mapping (QSM) for heart chamber oxygenation.
79:1545-1552.
2018
-
Cerebral Metabolic Rate of Oxygen (CMRO2) Mapping by Combining Quantitative Susceptibility Mapping (QSM) and Quantitative Blood Oxygenation Level-Dependent Imaging (qBOLD)
2018
-
Direct SAR mapping by thermoacoustic imaging: A feasibility study.
78:1599-1606.
2017
-
On the accurate analysis of vibroacoustics in head insert gradient coils.
78:1635-1645.
2017
-
Bone quantitative susceptibility mapping using a chemical species-specific R2* signal model with ultrashort and conventional echo data
2017
-
Coherence enhancement in quantitative susceptibility mapping by means of anisotropic weighting in morphology enabled dipole inversion
2017
-
MEDI+0: Morphology enabled dipole inversion with automatic uniform cerebrospinal fluid zero reference for quantitative susceptibility mapping
2017
-
Primal-dual and forward gradient implementation for quantitative susceptibility mapping
2017
-
Quantitative susceptibility mapping-based cerebral metabolic rate of oxygen mapping with minimum local variance
2017
-
Feasibility and reproducibility of whole brain myelin water mapping in 4 minutes using fast acquisition with spiral trajectory and adiabatic T2prep (FAST-T2) at 3T.
76:456-65.
2016
-
Multi-institutional validation of a novel textural analysis tool for preoperative stratification of suspected thyroid tumors on diffusion-weighted MRI.
75:1708-16.
2016
-
Cerebral metabolic rate of oxygen (CMRO2) mapping with hyperventilation challenge using quantitative susceptibility mapping (QSM)
2016
-
Preconditioned total field inversion (TFI) method for quantitative susceptibility mapping
2016
-
Rapid quantitative T2 mapping of the prostate using three-dimensional dual echo steady state MRI at 3T
2016
-
Susceptibility underestimation in a high-susceptibility phantom: Dependence on imaging resolution, magnitude contrast, and other parameters
2016
-
Patch based reconstruction of undersampled data (PROUD) for high signal-to-noise ratio and high frame rate contrast enhanced liver imaging.
74:1587-97.
2015
-
Flexible longitudinal magnetization contrast in spectrally overlapped 3D-MSI metal artifact reduction sequences: Technical considerations and clinical impact.
74:1349-55.
2015
-
Joint estimation of chemical shift and quantitative susceptibility mapping (chemical QSM).
73:2100-10.
2015
-
Algorithm for fast monoexponential fitting based on Auto-Regression on Linear Operations (ARLO) of data.
73:843-50.
2015
-
Enhancing k-space quantitative susceptibility mapping by enforcing consistency on the cone data (CCD) with structural priors
2015
-
Fast 3D T<inf>2</inf>-weighted imaging using variable flip angle transition into driven equilibrium (3D T<inf>2</inf>-TIDE) balanced SSFP for prostate imaging at 3T.
74:442-51.
2015
-
Quantification of cerebral perfusion using dynamic quantitative susceptibility mapping.
73:1540-8.
2015
-
Quantitative mapping of cerebral metabolic rate of oxygen (CMRO2) using quantitative susceptibility mapping (QSM).
74:945-52.
2015
-
Quantitative susceptibility mapping (QSM) of white matter multiple sclerosis lesions: Interpreting positive susceptibility and the presence of iron.
74:564-70.
2015
-
Rapid in vivo apparent diffusion coefficient mapping of hyperpolarized <sup>13</sup>C metabolites.
74:622-33.
2015
-
Direct coronary motion extraction from a 2D fat image navigator for prospectively gated coronary MR angiography.
71.
2014
-
An iterative spherical mean value method for background field removal in MRI.
72:1065-71.
2014
-
Flow compensated quantitative susceptibility mapping for venous oxygenation imaging.
72:438-45.
2014
-
Whole-heart coronary MRA with 100% respiratory gating efficiency: Self-navigated three-dimensional retrospective image-based motion correction (TRIM).
71:67-74.
2014
-
Integration of the computational fluid dynamics technique with MRI in aortic dissections.
69:1438-42.
2013
-
Fast 3D contrast enhanced MRI of the liver using temporal resolution acceleration with constrained evolution reconstruction.
69:370-81.
2013
-
Nonlinear formulation of the magnetic field to source relationship for robust quantitative susceptibility mapping.
69:467-76.
2013
-
Bayesian algorithm using spatial priors for multiexponential T2 relaxometry from multiecho spin echo MRI.
68:1536-43.
2012
-
Flip angle profile correction for T1 and T2 quantification with look-locker inversion recovery 2D steady-state free precession imaging.
68:1579-85.
2012
-
Reducing the object orientation dependence of susceptibility effects in gradient echo MRI through quantitative susceptibility mapping.
68:1563-9.
2012
-
Application of compressed sensing to multidimensional spectroscopic imaging in human prostate.
67:1499-505.
2012
-
T 2prep three-dimensional spiral imaging with efficient whole brain coverage for myelin water quantification at 1.5 tesla.
67:614-21.
2012
-
Morphology enabled dipole inversion (MEDI) from a single-angle acquisition: Comparison with COSMOS in human brain imaging.
66:777-83.
2011
-
Intravoxel incoherent motion imaging of tumor microenvironment in locally advanced breast cancer.
65:1437-47.
2011
-
A fast Edge-preserving Bayesian reconstruction method for Parallel Imaging applications in cardiac MRI..
65:184-9.
2011
-
Hippocampal blood flow in normal aging measured with arterial spin labeling at 3T..
65:128-137.
2011
-
Imaging near metal with a MAVRIC-SEMAC hybrid..
65:71-82.
2011
-
Respiratory and cardiac self-gated free-breathing cardiac CINE imaging with multiecho 3D hybrid radial SSFP acquisition.
63:1230-7.
2010
-
Separate MRI quantification of dispersed (ferritin-like) and aggregated (hemosiderin-like) storage iron.
63:1201-9.
2010
-
Effect of blood flow on double inversion recovery vessel wall MRI of the peripheral arteries: Quantitation with T2 mapping and comparison with flow-insensitive T2-prepared inversion recovery imaging.
63:736-44.
2010
-
Fat-free MRI based on magnetization exchange.
63:713-8.
2010
-
Hyperpolarized 13C spectroscopy and an NMR-compatible bioreactor system for the investigation of real-time cellular metabolism.
63:322-9.
2010
-
Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: Validation and application to brain imaging.
63:194-206.
2010
-
Proton MRS detects metabolic changes in hormone sensitive and resistant human prostate cancer models CWR22 and CWR22r.
62:1112-9.
2009
-
In vivo lactate signal enhancement using binomial spectral-selective pulses in selective MQ coherence (SS-SelMQC) spectroscopy.
62:591-8.
2009
-
Breathhold multiecho fast spin-echo pulse sequence for accurate R 2 measurement in the heart and liver.
62:300-6.
2009
-
Relaxation effects of ferucarbotran-labeled mesenchymal stem cells at 1.5T and 3T: Discrimination of viable from lysed cells.
62:325-32.
2009
-
Evaluation of the ERETIC method as an improved quantitative reference for 1H HR-MAS spectroscopy of prostate tissue.
61:525-32.
2009
-
Improved residue function and reduced flow dependence in MR perfusion using least-absolute-deviation regularization.
61:418-28.
2009
-
Calculation of susceptibility through multiple orientation sampling (COSMOS): A method for conditioning the inverse problem from measured magnetic field map to susceptibility source image in MRI.
61:196-204.
2009
-
Quantitative MR susceptibility mapping using piece-wise constant regularized inversion of the magnetic field.
60:1003-9.
2008
-
Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissues.
60:510-6.
2008
-
Kalman filtering for real-time navigator processing.
60:158-68.
2008
-
Quantification of choline- and ethanolamine-containing metabolites in human prostate tissues using 1H HR-MAS total correlation spectroscopy.
60:33-40.
2008
-
Feasibility of using limited-population-based arterial input function for pharmacokinetic modeling of osteosarcoma dynamic contrast-enhanced MRI data.
59:1183-9.
2008
-
Three-dimensional cine imaging using variable-density spiral trajectories and SSFP with application to coronary artery angiography.
58:535-43.
2007
-
On the noise correlation matrix for multiple radio frequency coils.
58:218-24.
2007
-
Modification of Gd-DTPA cystine copolymers with PEG-1000 optimizes pharmacokinetics and tissue retention for magnetic resonance angiography.
58:110-8.
2007
-
Bayesian parallel imagine with edge-preserving priors.
57:8-21.
2007
-
Reduction of reconstruction time for time-resolved spiral 3D contrast-enhanced magnetic resonance angiography using parallel computing.
56:704-8.
2006
-
Decomposed direct matrix inversion for fast non-Cartesian SENSE reconstructions.
56:356-63.
2006
-
Cardiac fat navigator-gated steady-state free precession 3D magnetic resonance angiography of coronary arteries.
56:210-5.
2006
-
High-resolution MAS NMR spectroscopy detection of the spin magnetization exchange by cross-relaxation and chemical exchange in intact cell lines and human tissue specimens.
55:1246-56.
2006
-
Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy.
55:1257-64.
2006
-
Automatic algorithm for correcting motion artifacts in time-resolved two-dimensional magnetic resonance angiography using convex projections.
55:649-58.
2006
-
Myocardial first pass perfusion: Steady-state free precession versus spoiled gradient echo and segmented echo planar imaging.
54:1123-9.
2005
-
Liver regeneration in humans is characterized by significant changes in cellular phosphorus metabolism: Assessment using proton-decoupled 31P-magnetic resonance spectroscopic imaging.
54:264-71.
2005
-
In vivo prostate magnetic resonance spectroscopic imaging using two-dimensional J-resolved PRESS at 3 T.
53:1177-82.
2005
-
Characterization of intervertebral disc degeneration by high-resolution magic angle spinning (HR-MAS) spectroscopy.
53:519-27.
2005
-
Exogenous contrast agent improves sensitivity of gradient-echo functional magnetic resonance imaging at 9.4 T.
52:1272-81.
2004
-
Imaging therapeutic response in human bone marrow using rapid whole-body MRI.
52:1234-8.
2004
-
In vivo tumor lactate relaxation measurements by Selective Multiple-Quantum-Coherence (Sel-MQC) transfer.
52:902-6.
2004
-
In vivo study of microbubbles as an MR susceptibility contrast agent.
52:445-52.
2004
-
View ordering for magnetization prepared steady state free precession acquisition: Application in contrast-enhanced MR angiography.
52:461-6.
2004
-
Multiprocessor scheduling implementation of the simultaneous multiple volume (SMV) navigator method.
52:362-7.
2004
-
High temporal and spatial resolution 4D MRA using spiral data sampling and sliding window reconstruction.
52:14-8.
2004
-
In vivo 5-fluorouracil and fluoronucleotide T1 relaxation time measurements using the variable nutation angle method.
52:169-73.
2004
-
Improved magnetization preparation for navigator steady-state free precession 3D coronary MR angiography.
51:1297-300.
2004
-
MRI Assessment of Neuropathology in a Transgenic Mouse Model of Alzheimer's Disease.
51:794-8.
2004
-
Isotropic susceptibility shift under MAS: The origin of the split water resonances in 1H MAS NMR spectra of cell suspensions.
50:515-21.
2003
-
Direct monitoring of coronary artery motion with cardiac fat navigator echoes.
50:235-41.
2003
-
Quantitative evaluation of susceptibility and shielding effects of nitinol, platinum, cobalt-alloy, and stainless steel stents.
49:972-6.
2003
-
High-resolution in vivo CBV mapping with MRI in wild-type mice.
49:765-70.
2003
-
In vivo multiple-mouse imaging at 1.5 T.
49:551-7.
2003
-
Automatic selection of mask and arterial phase images for temporally resolved MR digital subtraction angiography.
48:1004-10.
2002
-
Biochemical correlates of thiazolidinedione-induced adipocyte differentiation by high-resolution magic angle spinning NMR spectroscopy.
48:602-10.
2002
-
Recessed elliptical-centric view-ordering for contrast-enhanced 3D MR angiography of the carotid arteries.
48:419-24.
2002
-
k-space interpretation of the Rose Model: Noise limitation on the detectable resolution in MRI.
48:550-4.
2002
-
Fast maximum intensity projection algorithm using shear warp factorization and reduced resampling.
47:696-700.
2002
-
k-space weighted least-squares algorithm for accurate and fast motion extraction from magnetic resonance navigator echoes.
46:1037-40.
2001
-
Time-dependent effects of hormone-deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging.
46:49-57.
2001
-
Relative changes of cerebral arterial and venous blood volumes during increased cerebral blood flow: Implications for bold fMRI.
45:791-800.
2001
-
Regional sensitivity and coupling of BOLD, and CBV changes during stimulation of rat brain.
45:443-7.
2001
-
Effect of hyperoxia, hypercapnia, and hypoxia on cerebral interstitial oxygen tension and cerebral blood flow.
45:61-70.
2001
-
Simultaneous image acquisition utilizing hybrid body and phased array receiver coils.
44:660-3.
2000
-
Description of parallel imaging in MRI using multiple coils.
44:495-9.
2000
-
Clinical application of BASING and spectral/spatial water and lipid suppression pulses for prostate cancer staging and localization by in vivo 3D 1H magnetic resonance spectroscopic imaging.
43:17-22.
2000
-
A dual-tuned resonator for proton-decoupled phosphorus-31 chemical shift imaging of the brain.
41:809-15.
1999
-
Classification of human liposarcoma and lipoma using ex vivo proton NMR spectroscopy.
41:257-67.
1999
-
In vivo chemical shift imaging of γ-aminobutyric acid in the human brain.
41:35-42.
1999
-
Dynamic k-space filling for bolus chase 3D MR digital subtraction angiography.
40:99-104.
1998
-
Quantitative assessment of bone marrow hematopoiesis using parametric magnetic resonance imaging.
39:789-800.
1998
-
Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation.
39:615-24.
1998
-
Quantitative measurements of cerebral blood flow in rats using the FAIR technique: Correlation with previous iodoantipyrine autoradiographic studies.
39:564-73.
1998
-
Gradient, high-resolution, magic angle spinning 1H nuclear magnetic resonance spectroscopy of intact cells.
39:337-45.
1998
-
Identification of different lipid phases and calcium phosphate deposits in human carotid artery plaques by MAS NMR spectroscopy.
39:184-9.
1998
-
Timing algorithm for bolus chase MR digital subtraction angiography.
39:691-6.
1998
-
Study of the metabolism of choline and phosphatidylcholine in tumors in vivo using phosphonium-choline.
38:769-75.
1997
-
Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: Correlation with PET, microdialysis, and behavioral data.
38:389-98.
1997
-
Gradient, high-resolution, magic-angle spinning nuclear magnetic resonance spectroscopy of human adipocyte tissue.
38:399-403.
1997
-
Dispersion in magnetization transfer contrast at a given specific absorption rate due to variations of RF pulse parameters in the magnetization transfer preparation.
37:957-62.
1997
-
MR imaging and spectroscopy using hyperpolarized 129Xe gas: Preliminary human results.
37:809-15.
1997
-
Temporal lobe epilepsy: Correlation of proton magnetic resonance spectroscopy and 18F-fluorodeoxyglucose positron emission tomography.
37:18-23.
1997
-
Effect of 6-aminonicotinamide on the pentose phosphate pathway: 31P NMR and tumor growth delay studies.
36:887-92.
1996
-
3D MR angiography of pulmonary arteries using real-time navigator gating and magnetization preparation.
36:579-87.
1996
-
Dynamic MR digital subtraction angiography using contrast enhancement, fast data acquisition, and complex subtraction.
36:551-6.
1996
-
Sensitivity-enhanced echo-planar MRI at 1.5T using a 5 x 5 mesh dome resonator.
36:606-12.
1996
-
Effects of blood flow modifiers on tumor metabolism observed in vivo by proton magnetic resonance spectroscopic imaging.
36:204-11.
1996
-
Algorithms for extracting motion information from navigator echoes.
36:117-23.
1996
-
Multiple breathhold 3D time-of-flight MR angiography of the renal arteries.
35:426-34.
1996
-
Band-selective spin echoes for in vivo localized 1H NMR spectroscopy.
32:277-84.
1994
-
Glucose metabolism in RIF-1 tumors after reduction in blood flow: An in vivo 13C and 31P NMR study.
32:303-9.
1994
-
Rapid monitoring of changes in water diffusion coefficients during reversible ischemia in cat and rat brain.
31:454-60.
1994
-
Resolution enhanced NMR spectroscopy in biological systems via magnetic susceptibility matched sample immersion chambers.
30:754-8.
1993
-
Sensitivity and localization enhancement in multinuclear in vivo NMR spectroscopy by outer volume presaturation.
30:661-71.
1993
-
Determination of absolute phosphate metabolite concentrations in RIF-1 tumors in vivo by 31P-1H-2H NMR spectroscopy using water as an internal intensity reference.
28:105-21.
1992
-
In vivo sodium chemical shift imaging.
23:77-88.
1992
-
Quantitative MRI studies for assessment of multiple sclerosis.
24:90-9.
1992
-
In vivo measurements of bone marrow cellularity using volume-localized proton NMR spectroscopy.
19:85-95.
1991
-
In vivo monitoring of changes in 5‐fluorouracil metabolism induced by methotrexate measured by 19F NMR spectroscopy.
19:113-23.
1991
-
31P NMR spectra of extremity sarcomas: Diversity of metabolic profiles and changes in response to chemotherapy.
16:19-34.
1990
-
Androgen sensitivity of rat prostate carcinoma studied by 31P NMR spectroscopy, 1H MR imaging, and 23Na MR imaging.
11:152-60.
1989
-
MR in renal disease: Importance of cortical–medullary distinction.
5:160-72.
1987
-
Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker
2014
Identity
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)